PMID- 34265852 OWN - NLM STAT- MEDLINE DCOM- 20220131 LR - 20220131 IS - 1349-9157 (Electronic) IS - 0449-3060 (Print) IS - 0449-3060 (Linking) VI - 62 IP - 5 DP - 2021 Sep 13 TI - MHY1485 enhances X-irradiation-induced apoptosis and senescence in tumor cells. PG - 782-792 LID - 10.1093/jrr/rrab057 [doi] AB - The mammalian target of rapamycin (mTOR) is a sensor of nutrient status and plays an important role in cell growth and metabolism. Although inhibition of mTOR signaling promotes tumor cell death and several mTOR inhibitors have been used clinically, recent reports have shown that co-treatment with MHY1485, an mTOR activator, enhances the anti-cancer effects of anti-PD-1 antibody and 5-fluorouracil. However, it remains unclear whether MHY1485 treatment alters the effects of radiation on tumor cells. In this study, the radiosensitizing effects of MHY1485 were investigated using murine CT26 and LLC cell lines. We examined mTOR signaling, tumor cell growth, colony formation, apoptosis, senescence, oxidative stress, p21 accumulation and endoplasmic reticulum (ER) stress levels in cells treated with MHY1485 and radiation, either alone or together. We found that MHY1485 treatment inhibited growth and colony formation in both cell lines under irradiation and no-irradiation conditions, results that were not fully consistent with MHY1485's known role in activating mTOR signaling. Furthermore, we found that combined treatment with MHY1485 and radiation significantly increased apoptosis and senescence in tumor cells in association with oxidative stress, ER stress and p21 stabilization, compared to radiation treatment alone. Our results suggested that MHY1485 enhances the radiosensitivity of tumor cells by a mechanism that may differ from MHY1485's role in mTOR activation. CI - (c) The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. FAU - Sun, Lue AU - Sun L AD - Health and Medical Research Institute, Department of Life Science and Biotechnology, National Institute of Advanced Industrial Science and Technology (AIST), Central 6, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan. FAU - Morikawa, Kumi AU - Morikawa K AD - Health and Medical Research Institute, Department of Life Science and Biotechnology, National Institute of Advanced Industrial Science and Technology (AIST), Central 6, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan. FAU - Sogo, Yu AU - Sogo Y AD - Health and Medical Research Institute, Department of Life Science and Biotechnology, National Institute of Advanced Industrial Science and Technology (AIST), Central 6, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan. FAU - Sugiura, Yuki AU - Sugiura Y AD - Health and Medical Research Institute, Department of Life Science and Biotechnology, National Institute of Advanced Industrial Science and Technology (AIST), 2217-14, Hayashi-cho, Takamatsu, Kagawa 761-0895, Japan. LA - eng GR - 19 K22586/Japan Society for the Promotion of Science/ PT - Journal Article PL - England TA - J Radiat Res JT - Journal of radiation research JID - 0376611 RN - 0 (4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine) RN - 0 (Morpholines) RN - 0 (Neoplasm Proteins) RN - 0 (Triazines) RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Animals MH - Apoptosis/*drug effects/radiation effects MH - Carcinoma, Lewis Lung/genetics/pathology MH - Cell Cycle/drug effects/radiation effects MH - Cell Line, Tumor MH - Cellular Senescence/*drug effects/radiation effects MH - Colonic Neoplasms/genetics/pathology MH - Drug Screening Assays, Antitumor MH - Endoplasmic Reticulum Stress/drug effects/radiation effects MH - Genes, p53 MH - Genes, ras MH - Lipid Peroxidation/drug effects/radiation effects MH - Mice MH - Mitochondria/drug effects/radiation effects MH - Morpholines/*pharmacology MH - Neoplasm Proteins/*agonists/biosynthesis/genetics MH - Signal Transduction/drug effects/radiation effects MH - TOR Serine-Threonine Kinases/*drug effects MH - Triazines/*pharmacology MH - Tumor Stem Cell Assay PMC - PMC8438247 OTO - NOTNLM OT - MHY1485 OT - apoptosis OT - mammalian target of rapamycin (mTOR) OT - radiation OT - senescence EDAT- 2021/07/16 06:00 MHDA- 2022/02/01 06:00 PMCR- 2021/07/16 CRDT- 2021/07/15 20:36 PHST- 2021/02/24 00:00 [received] PHST- 2021/05/27 00:00 [revised] PHST- 2021/07/16 06:00 [pubmed] PHST- 2022/02/01 06:00 [medline] PHST- 2021/07/15 20:36 [entrez] PHST- 2021/07/16 00:00 [pmc-release] AID - 6322308 [pii] AID - rrab057 [pii] AID - 10.1093/jrr/rrab057 [doi] PST - ppublish SO - J Radiat Res. 2021 Sep 13;62(5):782-792. doi: 10.1093/jrr/rrab057.